Berenberg Bank Has Lowered Expectations for Craneware (LON:CRW) Stock Price

Craneware (LON:CRW) had its price target reduced by research analysts at Berenberg Bank from GBX 2,900 to GBX 2,600 in a research report issued to clients and investors on Friday,London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 115.39% from the stock’s current price.

Separately, UBS Group reiterated a “buy” rating and set a GBX 570 price objective on shares of Craneware in a report on Wednesday, March 25th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of GBX 2,222.75.

Craneware Stock Performance

CRW stock opened at GBX 1,207.10 on Friday. The firm has a market cap of £413.27 million, a PE ratio of 19.19 and a beta of 0.28. The stock has a 50-day moving average price of GBX 1,468.78 and a 200-day moving average price of GBX 1,561.49. The company has a current ratio of 0.76, a quick ratio of 1.00 and a debt-to-equity ratio of 7.93. Craneware has a 1-year low of GBX 988 and a 1-year high of GBX 2,644.

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.